Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 14.12% is 65% below its 1-year average of 40.00%, near the low end of its 1-year range (0.00%–100.00%).
64.70% below its 12-month average of 40.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
14.12%
GROSS MARGIN AVG TTM
40.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
5.17%
GROSS MARGIN AVG 20Y
13.59%
CURRENT VS TTM AVG
-64.70%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+172.86%
CURRENT VS 20Y AVG
+3.89%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-65.88%
vs the sector median at left
Lisata Therapeutics, Inc.
Market Cap
$11.29M
Gross Margin
14.12%
TTM Avg
40.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.39M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
-4489.78%
Market Cap
$11.46M
Gross Margin
59.22%
TTM Avg
55.56%
3Y Avg
55.56%
5Y Avg
55.56%
Market Cap
$11.12M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$11.55M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.00M
Gross Margin
N/A
TTM Avg
-101.19%
3Y Avg
-33.23%
5Y Avg
-22.16%
Market Cap
$10.94M
Gross Margin
89.58%
TTM Avg
88.41%
3Y Avg
-34.57%
5Y Avg
-154.89%
Market Cap
$11.77M
Gross Margin
36.23%
TTM Avg
36.65%
3Y Avg
39.59%
5Y Avg
41.13%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | $11.29M | 14.12% | 40.00% | 0.00% | 0.00% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.39M | 0.00% | 50.00% | 25.00% | -4489.78% |
| Caring Brands, Inc. (CABR)vs › | $11.46M | 59.22% | 55.56% | 55.56% | 55.56% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | 100.00% | 100.00% | 100.00% | 100.00% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioVie Inc. (BIVI)vs › | $11.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | N/A | -101.19% | -33.23% | -22.16% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 89.58% | 88.41% | -34.57% | -154.89% |
| IRIDEX Corporation (IRIX)vs › | $11.77M | 36.23% | 36.65% | 39.59% | 41.13% |
| Pluri Inc. (PLUR)vs › | $10.68M | 44.59% | 46.77% | 72.29% | -10.14% |
Gross Margin
14.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 50.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | -1.51% |
| 2016-12-31 | 9.15% |
| 2016-09-30 | 7.58% |
| 2016-06-30 | 15.05% |
| 2016-03-31 | 16.84% |
| 2015-12-31 | 18.21% |
| 2015-09-30 | 18.34% |
| 2015-06-30 | 1.16% |
| 2015-03-31 | -6.18% |
| 2014-12-31 | 21.09% |
| 2014-09-30 | 2.56% |
| 2014-06-30 | 18.08% |
| 2014-03-31 | 5.67% |
| 2013-12-31 | 18.00% |
| 2013-09-30 | -76.09% |
| 2013-06-30 | 2.85% |
| 2013-03-31 | 5.22% |
| 2012-12-31 | 8.77% |
| 2012-09-30 | 15.48% |
| 2012-06-30 | 18.86% |
| 2012-03-31 | 26.00% |
| 2011-12-31 | 19.73% |
| 2011-09-30 | 22.05% |
| 2011-06-30 | 26.78% |
| 2011-03-31 | 27.22% |
| 2010-12-31 | 19.07% |
| 2010-09-30 | 31.82% |
| 2010-06-30 | 33.47% |
| 2010-03-31 | 31.47% |
| 2009-12-31 | 34.30% |
| 2009-09-30 | 37.55% |
| 2009-06-30 | 50.16% |
| 2009-03-31 | 47.83% |
| 2008-12-31 | 43.55% |
| 2008-09-30 | 64.99% |
| 2008-06-30 | 83.39% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 90.80% |
| 2007-09-30 | 46.05% |
| 2007-06-30 | 60.94% |
| 2007-03-31 | 97.76% |
| 2006-12-31 | 66.60% |
| 2006-09-30 | 28.66% |
| 2006-06-30 | 28.66% |
| 2006-03-31 | 28.66% |
| 2005-12-31 | 29.10% |
| 2005-09-30 | 30.03% |
| 2005-06-30 | 30.11% |
| 2005-03-31 | 29.60% |
| 2004-12-31 | 30.43% |
| 2004-09-30 | 33.83% |
| 2004-06-30 | 31.13% |
| 2004-03-31 | 29.51% |
| 2003-12-31 | 46.39% |
| 2003-09-30 | 29.21% |
| 2003-06-30 | 28.39% |
| 2003-03-31 | 28.22% |
| 2002-12-31 | 28.07% |
| 2002-09-30 | 29.07% |
